Videos

  • GDPR @ EORTC

    GDPR at EORTC

  • Tailoring medicine to patient needs - Video illustration

    Tailoring medicine to patient needs

  • EORTC: The future of cancer therapy #WeAreEORTC

    EORTC: The future of cancer therapy #WeAreEORTC

  • EORTC World Cancer Day 2019

    2019 World Cancer Day

Press Releases

  • News,Press release,Quality of Life Group

    EORTC Quality of Life Group celebrating 40 years

  • EORTC Item Library provides considerable coverage of CTCAE side effects

    News,Press release,Quality of Life Group

    EORTC Item Library provides considerable coverage of CTCAE side effects, new study finds

  • PRESS RELEASE: Better treatment for better heath: lifting the veil on treatment optimisation

    News,Press release

    PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation

  • Lung

    Lung Cancer Group,News,Press release

    MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression

Latest Newsletters

News

Filter on topic
  • EORTC & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer

    Breast Cancer Group,News

    EORTC & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer

  • LEGATO Glioblastoma brain scan

    Brain Tumour Group,News

    The EU funded project LEGATO officially started

  • Middle East Ambassador

    News

    EORTC strategic meeting with Middle Eastern Ambassadors

  • ISOQOL Conference 2023 News release

    News,Quality of Life Group

    EORTC Quality of Life Group projects to be presented at ISOQOL 2023

  • Sarcoma Awareness Month STREXIT 2

    News,Soft Tissue and Bone Sarcoma Group

    Celebrating Sarcoma Awareness Month with the start of EU-funded STREXIT 2 project study

  • EORTC Awardees of the PTCOG Research Award 2023

    News

    “Best Proposal in Medicine” award received by EORTC at the PTCOG 61 Conference

  • Hodgkin-Lymphoma

    Lymphoma Group,News

    Long-term efficacy and safety outcomes of the EORTC/LYSA/FIL H10 trial assessing early PET-scan adapted treatment of limited stage Hodgkin lymphoma

  • Joint Statement(EHDS)-banner

    News

    Joint Statement: health organisations define EHDS’ opt out required for life saving research

  • Hans-Wilders-Award

    News

    Congratulations to Dr. Hans Wildiers, winner of the B.J. Kennedy Geriatric Oncology Award